Metastatic Breast Cancer Network Presents NCIs Dr. Patricia Steeg with the Ellen Moskowitz and Suzanne Hebert Leadership Grant Award
Summary
New York, NY, October 24, 2012 --( “For the last 20 years, in her laboratory at the National Cancer Institute, in Bethesda, Maryland, Dr. Patricia Steeg has been researching how cancer cells from the primary tumor in the breast travel to vital organs, in particular the brain,” said Shirley Mertz, MBCN board member and prominent patient advocate.She exerts strong leadership in the research community nationally and internationally.” The award—which includes a monetary grant to be used for metastatic research—is named after MBCN’s former President, Ellen Moskowitz, and former Vice-President, Suzanne Hebert.Mertz presented the award to Steeg “with great appreciation and anticipation for the future...along with our deep thanks for your dedication and persistence in metastasis research.” Prior to accepting the award, Steeg gave a presentation on “Research on Treatment to Contain Metastatic Growth.” The researcher made a case for redesigning clinical trials to do what she termed “phase II randomized metastasis-prevention trials.” Currently, phase I and phase II clinical trials are done in patients with advanced, refractory metastatic cancer, patients who have had many therapies.She exerts strong leadership in the research community nationally and internationally.”The award—which includes a monetary grant to be used for metastatic research—is named after MBCN’s former President, Ellen Moskowitz, and former Vice-President, Suzanne Hebert.Steeg is in the trenches helping us and it showed!’ We are proud to recognize and support Dr. Steeg’s work.”About MBCN’s Annual ConferenceMBCN held its first conference at Memorial Sloan-Kettering Cancer Center in 2006.